Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Person › Details

Rodger Novak (CRISPR Therapeutics AG (Nasdaq: CRSP))

Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH)

 

Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Former/major organisation SR One Capital Management
  Group SR One (Group)
Products Product CRISPR gene editing technology
  Product 2 anti-infective drug
     

   
Record changed: 2024-04-24

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px


More documents for Rodger Novak


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top